News EU drug regulators concerned about Brexit impact European regulators concerned over impact of EMA move.
News Novartis less exposed to US pricing pressure, says Jimenez Europe and Asia account for a large share of company's income.
Views & Analysis Recent trends in ANDA litigation Sheila Swaroop and Kaitlin Heinen examine the findings of a recent report.
News Allergan ‘not looking for big deals’ as growth slows Company will put its $27 billion to use, however
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
